Jiangsu Hengrui Pharmaceuticals Co Ltd banner

Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276

Watchlist Manager
Jiangsu Hengrui Pharmaceuticals Co Ltd Logo
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Watchlist
Price: 55.2 CNY -3.26% Market Closed
Market Cap: ¥352.1B

Balance Sheet

Balance Sheet Decomposition
Jiangsu Hengrui Pharmaceuticals Co Ltd

Balance Sheet
Jiangsu Hengrui Pharmaceuticals Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
119
128
363
431
566
573
385
707
995
949
1 329
2 169
3 449
5 133
4 912
4 262
3 866
5 031
10 731
13 607
15 110
20 746
24 802
40 855
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13 120
14 537
20 272
24 239
40 855
Cash Equivalents
119
128
363
431
566
573
385
707
995
949
1 329
2 169
3 449
5 133
4 912
4 262
3 866
5 031
10 731
487
573
475
563
0
Short-Term Investments
83
73
0
0
11
271
80
0
0
0
0
0
0
0
1 594
4 550
7 063
8 607
5 628
5 090
2 760
99
273
114
Total Receivables
314
384
326
291
265
556
889
1 234
1 726
2 173
2 492
2 609
2 987
3 472
3 795
4 531
5 517
6 462
9 277
7 659
9 050
6 681
6 422
6 319
Accounts Receivables
215
226
157
155
141
439
612
855
1 162
1 251
1 443
1 560
1 796
2 092
2 325
3 189
3 773
4 906
5 074
4 633
5 891
5 194
4 915
5 147
Other Receivables
99
158
169
136
124
117
277
379
564
922
1 049
1 049
1 191
1 380
1 470
1 342
1 744
1 556
4 203
3 027
3 159
1 487
1 507
1 173
Inventory
96
113
63
69
98
120
162
177
176
300
338
430
551
523
637
790
1 031
1 607
1 778
2 403
2 451
2 314
2 417
2 878
Other Current Assets
17
37
6
10
5
13
36
30
94
309
355
204
213
251
455
335
593
604
635
1 428
1 562
1 447
1 400
1 324
Total Current Assets
628
736
759
801
945
1 532
1 553
2 148
2 991
3 731
4 514
5 412
7 200
9 378
11 393
14 469
18 069
22 311
28 050
30 188
30 934
31 287
35 315
51 490
PP&E Net
549
692
491
480
480
472
515
559
761
984
1 269
1 564
1 624
1 770
2 474
3 079
3 686
4 075
4 585
6 725
6 999
6 964
7 407
8 519
PP&E Gross
549
692
491
480
480
472
515
559
761
984
1 269
1 564
1 624
1 770
2 474
3 079
3 686
4 075
4 585
6 725
6 999
6 964
7 407
8 519
Accumulated Depreciation
135
179
94
137
188
240
296
357
422
516
640
784
983
1 111
1 344
1 636
1 996
2 574
2 924
3 382
3 903
4 425
5 052
5 687
Intangible Assets
14
14
1
0
29
30
29
50
52
51
67
203
200
196
285
279
273
350
341
702
2 201
3 376
5 030
6 834
Long-Term Investments
1
1
4
4
4
4
103
192
41
5
5
5
5
79
81
118
156
599
1 502
1 001
1 508
1 451
1 732
2 030
Other Long-Term Assets
12
8
0
0
10
20
54
49
50
46
37
37
58
73
97
95
177
221
251
651
729
706
652
993
Total Assets
1 205
N/A
1 451
+20%
1 255
-14%
1 285
+2%
1 468
+14%
2 058
+40%
2 254
+10%
2 999
+33%
3 896
+30%
4 818
+24%
5 893
+22%
7 220
+23%
9 087
+26%
11 497
+27%
14 330
+25%
18 039
+26%
22 361
+24%
27 556
+23%
34 730
+26%
39 266
+13%
42 371
+8%
43 785
+3%
50 136
+15%
69 867
+39%
Liabilities
Accounts Payable
50
64
66
58
46
93
132
139
197
200
220
282
396
492
755
734
1 381
1 289
1 326
1 787
1 487
1 510
1 967
2 270
Accrued Liabilities
56
78
49
41
72
130
78
126
119
107
0
78
99
91
233
357
66
185
139
181
110
152
165
138
Short-Term Debt
121
232
59
0
0
113
0
0
0
0
0
8
23
14
85
59
113
315
408
563
1 709
170
251
69
Current Portion of Long-Term Debt
50
39
20
0
0
0
0
0
0
10
0
10
0
10
0
0
0
0
0
0
0
0
41
31
Other Current Liabilities
29
22
43
24
34
41
20
60
85
113
220
107
333
446
292
900
934
683
1 899
871
334
721
1 209
3 861
Total Current Liabilities
305
433
237
123
153
377
230
324
401
429
440
485
851
1 053
1 365
2 050
2 494
2 473
3 772
3 402
3 639
2 554
3 634
6 369
Long-Term Debt
90
114
20
48
48
0
0
10
20
10
10
10
10
0
0
0
0
0
0
152
99
75
69
43
Deferred Income Tax
0
0
0
0
0
25
0
0
0
0
0
0
0
0
0
0
0
24
30
25
100
84
117
117
Minority Interest
18
17
14
13
11
17
30
57
87
154
228
299
355
426
486
575
70
162
283
569
589
567
570
525
Other Liabilities
0
0
0
6
0
0
0
0
0
0
0
69
72
86
91
46
70
122
141
117
119
39
226
1 541
Total Liabilities
412
N/A
564
+37%
272
-52%
190
-30%
212
+12%
420
+98%
260
-38%
391
+50%
508
+30%
594
+17%
678
+14%
863
+27%
1 289
+49%
1 565
+21%
1 942
+24%
2 672
+38%
2 633
-1%
2 781
+6%
4 225
+52%
4 263
+1%
4 547
+7%
3 319
-27%
4 616
+39%
8 595
+86%
Equity
Common Stock
255
255
255
255
332
431
517
621
749
1 124
1 237
1 360
1 505
1 956
2 347
2 833
3 686
4 423
5 332
6 396
6 379
6 379
6 379
6 637
Retained Earnings
142
237
283
389
606
869
1 162
1 672
2 210
2 787
3 651
4 667
5 924
7 644
9 646
12 076
15 207
19 103
23 530
25 928
28 819
32 102
37 164
43 601
Additional Paid In Capital
395
395
395
395
318
338
316
316
429
314
328
332
508
420
438
987
1 479
1 663
3 143
3 356
3 020
3 058
3 188
12 935
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
136
88
43
528
634
420
1 495
665
398
1 092
1 229
1 929
Other Equity
0
0
51
56
0
0
0
1
1
1
1
1
2
2
0
0
10
7
5
12
3
19
17
28
Total Equity
792
N/A
887
+12%
984
+11%
1 095
+11%
1 256
+15%
1 638
+30%
1 994
+22%
2 608
+31%
3 387
+30%
4 224
+25%
5 214
+23%
6 357
+22%
7 798
+23%
9 931
+27%
12 388
+25%
15 368
+24%
19 728
+28%
24 775
+26%
30 504
+23%
35 003
+15%
37 824
+8%
40 466
+7%
45 520
+12%
61 272
+35%
Total Liabilities & Equity
1 205
N/A
1 451
+20%
1 255
-14%
1 285
+2%
1 468
+14%
2 058
+40%
2 254
+10%
2 999
+33%
3 896
+30%
4 818
+24%
5 893
+22%
7 220
+23%
9 087
+26%
11 497
+27%
14 330
+25%
18 039
+26%
22 361
+24%
27 556
+23%
34 730
+26%
39 266
+13%
42 371
+8%
43 785
+3%
50 136
+15%
69 867
+39%
Shares Outstanding
Common Shares Outstanding
6 254
6 254
6 254
6 254
6 254
6 254
6 254
6 254
6 292
6 292
6 292
6 292
4 840
6 305
6 316
6 318
6 328
6 350
6 356
6 382
6 370
6 355
6 379
6 637
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett